Concepedia

Publication | Closed Access

Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study

104

Citations

24

References

2014

Year

Abstract

A few clinical and immunological study parameters have suggested improved outcomes in patients receiving high-dose (2 × 1000 mg) rituximab.

References

YearCitations

Page 1